Indraprastha Medical Corporation Ltd (INDRAMEDCO) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Indraprastha Medical Corporation Ltd on NSE and BSE, with an AI summary of each filing.
Indraprastha Medical Corporation Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Outcome · 29 Oct 2026, 10:09 pm
We are enclosing herewith the Un-audited Financial Results for the quarter and half yearly ended 30th September 2026, along with a copy of the Limited Review Report by the Statutory Auditors ....
Outcome · 29 Oct 2026, 10:04 pm
Indraprastha Medical Corporation Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Crore) ■ Revenue: 413 (+8.4% YoY | +1.6% QoQ) ■ EBITDA: 77.4 (+8.6% YoY | -3.0% QoQ) ■ EBITDA Margin (%): 18.8 (+4 bps YoY | -89 bps QoQ) ■ PAT: 53.6 (+8.3% YoY | -4.1% QoQ) ■ EPS (INR): 5.84 (+8.1% YoY | -4.1% QoQ)
To consider and approve the financial results for the period ended September 30, 2026
Intimation · 29 Oct 2026, 5:30 am
Indraprastha Medical Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve It is hereby ....
Intimation · 29 Oct 2026, 5:30 am
Indraprastha Medical Corporation Board Meeting Scheduled for 29th Oct'26 Indraprastha Medical Corporation Limited has informed exchanges that its Board of Directors will meet on 29th Oct'26. The board will consider and approve the unaudited financial results of the company for the quarter and half year ended 30th Sep'26, pursuant to Regulation 29 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
INDRAPRASTHA MEDICAL CORPORATION LIMITED has informed the Exchange about Board Meeting to be held on 29-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 .
Intimation · 29 Oct 2026, 5:30 am
The 38th AGM of the company was held on 24th September, 2026 through VC and OAVM and the buisness mentioned in the notice dated 6th August, 2026 was transacted. Enclosed please find the ....
Annual General Meeting · 25 Sept 2026, 6:45 pm
We hereby submit per annexure summary of the proceedings of the 38th AGM of the Company held on 24th September, 2026, through video confrencing and other audio- visual means.
Annual General Meeting · 24 Sept 2026, 9:19 pm
Pursuant to Regulation 34(1)(a) & 53(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Annual Report of the Company for the financial year ended 31st ....
Others (Uncategorized) · 01 Sept 2026, 6:16 pm
Enclosed please find the Annual Report of the company for the financial year ended 31st March, 2026 along with the notice of the 38th AGM , to be held on 24th September, 2026, and, Business ....
Annual General Meeting · 01 Sept 2026, 6:11 pm
1)The AGM of the Company will be held on Thursday, 24th September, 2026. 2) The Record date for purpose of declaration of Dividend is 18th September, 2026. 3) The cut-off date for ....
Annual General Meeting · 29 Aug 2026, 9:38 pm
The board of directors of the company has at its meeting held on 6th August, 2026 considered and approved convening the 38th AGM of the company on 24th September, 2026 through Video Conferencing\ ....
Annual General Meeting · 07 Aug 2026, 12:14 am
The board of director of the company as its meeting held on 06-08-2026 considered and approved fixation of record date as Friday 18-09-2026 for the purpose of payment of dividend for the ....
Dividend · 07 Aug 2026, 12:07 am
INDRAMEDCO: Q1'27 PAT Rises 8.5% YoY, Record Date Set for Dividend Indraprastha Medical Corporation reported Q1'27 PAT of ₹55.85 crore, up 8.5% YoY and 33.9% QoQ. Revenue from operations grew 11.3% YoY to ₹406.15 crore, while total expenses increased by 11.9% YoY. Profit before tax (PBT) stood at ₹74.82 crore, a 9.5% YoY rise. EPS for the quarter was ₹6.09, compared to ₹5.61 in Q1'26. The Board approved the 38th AGM for 24th Sep'26 and set a record date of 18th Sep'26 for the FY25-26 dividend.
This is to inform that the Board of Directors of the Company has, at its meeting held on Thursday, 6th August, 2026 (i.e. today), inter-alia, considered and approved the following items: ....
Outcome · 07 Aug 2026, 12:00 am
Indraprastha Medical Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 ,inter alia, to consider and approve It is hereby ....
Intimation · 06 Aug 2026, 5:30 am
Indraprastha Medical Corp Sets Board Meeting for Q1FY27 Results Indraprastha Medical Corporation Ltd (INDRAMEDCO) has scheduled a Board of Directors meeting for Thu, 6th Aug'26. The agenda includes the consideration and approval of the unaudited financial results for the first quarter ending 30th Jun'26. This announcement was made pursuant to SEBI's Regulation 29.
We wishh to inform you that the management of the company intends to engage in discussions with investors/analyst meet on 4th June, 2026 & 5th June, 2026 at Mumbai. Further, please note ....
Intimation · 02 Jun 2026, 3:23 pm
INDRAMEDCO Schedules Investor Meetings with Major Funds Indraprastha Medical Corporation (INDRAMEDCO) has scheduled one-on-one investor meetings in Mumbai on 4th Jun'26 and 5th Jun'26. Management will meet with several prominent domestic institutional investors, including HDFC, AXIS, SBI, Nippon, and UTI Mutual Funds. Other participants include PineBridge Investments, InCred AMC, and various PMS firms. The company confirmed that no unpublished price-sensitive information will be disclosed during these engagements. The schedule remains subject to change.
we wish to inform you that ICRA Limited has vide its letter dated 26th May, 2026, re-affirmed its rating on the long term bank facility and instrumnet of Indraprasth Medical Corporation ....
Others (Uncategorized) · 27 May 2026, 8:41 pm
Indraprastha Medical Credit Ratings Reaffirmed by ICRA On 26th May'26, ICRA reaffirmed its credit ratings for Indraprastha Medical Corp's bank facilities totaling Rs. 162.50 crore. The long-term rating for fund-based term loans (Rs. 92.50 Cr) and cash credit (Rs. 40.00 Cr) was maintained at [ICRA]AA(Stable). The short-term rating for non-fund based facilities (Rs. 30.00 Cr) was also reaffirmed at [ICRA]A1+. The stable outlook reflects a high degree of safety regarding timely servicing of financial obligations and very strong credit quality.
the board of directors of the company inter-alia : 1. Approved the audited finacial results for the quater/year ended 31st March, 2026, 2. Reccomended a dividend @ 40% i.e., Rs 4 per ....
Outcome · 12 May 2026, 11:16 pm
Indraprastha Medical Corporation Limited - Financial Result for the Quarter ended 31st Mar'26 (Standalone, INR Crore) ■ Revenue: 365 (+9.3% YoY | -1.8% QoQ) ■ EBITDA: 60.5 (-1.3% YoY | -2.3% QoQ) ■ EBITDA Margin (%): 16.6 (-179 bps YoY | -8 bps QoQ) ■ PAT: 41.7 (+1.7% YoY | +1.7% QoQ) ■ EPS (INR): 4.55 (+1.8% YoY | +1.8% QoQ)
Indraprastha Medical Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2026 ,inter alia, to consider and approve Pursuant to ....
Intimation · 12 May 2026, 5:30 am
Indraprastha Medical Corp Board to Review Q4FY26 Results and Dividend Indraprastha Medical Corporation Ltd (INDRAMEDCO) has scheduled a Board of Directors meeting for 12th May'26. The agenda includes the consideration and approval of the audited financial results for the quarter and year ended 31st Mar'26. Additionally, the board will consider and recommend a potential dividend on equity shares for the financial year 2025-26. The outcome of these discussions will be a key focus for investors.
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Others (Uncategorized) · 23 Apr 2026, 3:48 pm
Indraprastha Medical Corp Not Classified as a Large Corporate by SEBI On 23rd Apr'26, Indraprastha Medical Corporation Ltd (INDRAMEDCO) informed exchanges that it does not meet SEBI's criteria to be classified as a "Large Corporate." This status exempts the company from the mandatory requirement to raise a portion of its funding through debt securities. The company reported NIL outstanding borrowings as of 31st Mar'26 and holds a credit rating of [ICRA]AA. This declaration clarifies the company's capital raising framework and obligations under SEBI regulations.
We hereby inform you that Mr. Vinayak Chatterjee (DIN: 00008933) has completed his tenure viz. second term of five consecutive years on 31st March, 2026, as Independent Director on the ....
Change in Management · 01 Apr 2026, 8:19 pm
Indraprastha Medical Corp: Independent Director Vinayak Chatterjee Completes Tenure Indraprastha Medical Corporation announced that Independent Director Mr. Vinayak Chatterjee (DIN 00008933) has completed his tenure. His second term of five consecutive years concluded on 31st Mar'26. Consequently, he ceased to be a Director and Member/Chairperson of respective Board committees effective the same date. The departure is due to the completion of his mandated term.
It is hereby informed the board of directors in its meeting held on 03.02.2026, considered and approved the appionment/ re-appiontment of the following : 1. Mr. Harsh Pati Singhania as ....
Change in Management · 04 Feb 2026, 12:38 am
INDRAMEDCO Board Approves Q3FY26 Results, Confirms Director Appointments Indraprastha Medical's board approved unaudited financial results for the quarter and nine months ended 31st Dec'25. Q3FY26 PAT stood at ₹41.00 crore, down 17.1% QoQ but up 25.0% YoY, while revenue was ₹371.61 crore. The board appointed Harsh Pati Singhania as an Independent Director for a 5-year term from 3rd Feb'26. It also re-appointed Salil Singhal, Vineeta Rai, and Madhumita Ganguli as Independent Directors for 5-year terms. An additional affidavit regarding a land lease matter at its Sarita Vihar hospital was noted.
Pursuant to Regulation 30 and 33 read with Schedule III of the SEBI ( Listing Obligations and Disclosure Requirements) Regulations, 2015 the Board of Directors of the Company at its meeting ....
Outcome · 03 Feb 2026, 11:50 pm
Indraprastha Medical Corporation Limited - Financial Result for the Quarter ended 31st Dec'25 (Standalone, INR Crore) ■ Revenue: 372 (+14.4% YoY | -2.5% QoQ) ■ EBITDA: 62.0 (+18.7% YoY | -13.1% QoQ) ■ EBITDA Margin (%): 16.7 (+61 bps YoY | -204 bps QoQ) ■ PAT: 41.0 (+25.0% YoY | -17.1% QoQ) ■ EPS (INR): 4.47 (+24.9% YoY | -17.2% QoQ)
Indraprastha Medical Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 ,inter alia, to consider and approve It is hereby ....
Intimation · 03 Feb 2026, 5:30 am
Indraprastha Medical Corp Sets Board Meeting for Q3 FY26 Results Indraprastha Medical Corporation Ltd (INDRAMEDCO) has scheduled a Board of Directors meeting for 3rd Feb'26. The agenda includes the consideration and approval of the unaudited financial results for the quarter and nine months ended 31st Dec'25. This meeting is pursuant to Regulation 29 of SEBI (LODR) Regulations, 2015.
we wish to submit that the management of the company intends to participate in the "annual flagship Conference- Anand Rathi G-200 Submit on 13th November, 2025 at Mumbai.
Intimation · 10 Nov 2025, 10:48 pm
The Board of Directors of the company has at its meeting held on Saturday 1st November 2025, i.e. today, inter alia, consider and approved the un-audited financial results for the quarter ....
Outcome · 01 Nov 2025, 10:11 pm